(Q38020245)

27 August 2017

title

Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when (English)

1 reference

27 August 2017

1 reference

Axel Bex

1

1 reference

27 August 2017

Tom Powles

series ordinal

2

1 reference

27 August 2017

publication date

1 June 2012

1 reference

Expert Review of Anticancer Therapy

27 August 2017

published in

1 reference

27 August 2017

volume

12

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

787-797

1 reference

Estimates of the cancer incidence and mortality in Europe in 2006.

27 August 2017

cites work

1 reference

Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy

21 January 2018

1 reference

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

21 January 2018

1 reference

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

21 January 2018

1 reference

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome

21 January 2018

1 reference

Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?

21 January 2018

1 reference

Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.

21 January 2018

1 reference

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer

21 January 2018

1 reference

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis

21 January 2018

1 reference

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Sunitinib for treatment of advanced renal cell cancer: primary tumor response

21 January 2018

1 reference

Role of cytoreductive nephrectomy in the era of targeted therapy for renal cell carcinoma

21 January 2018

1 reference

Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy

21 January 2018

1 reference

The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy

21 January 2018

1 reference

Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands.

21 January 2018

1 reference

Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials

21 January 2018

1 reference

Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma

21 January 2018

1 reference

Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib

21 January 2018

1 reference

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy.

21 January 2018

1 reference

Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity

21 January 2018

1 reference

Immune resistance orchestrated by the tumor microenvironment

21 January 2018

1 reference

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

21 January 2018

1 reference

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

21 January 2018

1 reference

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.

21 January 2018

1 reference

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained

21 January 2018

1 reference

MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy

21 January 2018

1 reference

Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.

21 January 2018

1 reference

Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

21 January 2018

1 reference

Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.

21 January 2018

1 reference

Thirty-day mortality after nephrectomy: clinical implications for informed consent

21 January 2018

1 reference

Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery

21 January 2018

1 reference

Renal artery embolisation in the palliative treatment of renal carcinoma

21 January 2018

1 reference

A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

21 January 2018

1 reference

Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma

21 January 2018

1 reference

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

21 January 2018

1 reference

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

21 January 2018

1 reference

Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?

21 January 2018

1 reference

Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy?

21 January 2018

1 reference

Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy

21 January 2018

1 reference

Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma

21 January 2018

1 reference

Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma

21 January 2018

1 reference

Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma

21 January 2018

1 reference

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer

21 January 2018

1 reference

Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib

21 January 2018

1 reference

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

EAU guidelines on renal cell carcinoma: the 2010 update

21 January 2018

1 reference

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

21 January 2018

1 reference

Fibroblast growth factor 2 regulates endothelial cell sensitivity to sunitinib.

21 January 2018

1 reference

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

21 January 2018

1 reference

Sequential use of targeted agents in the treatment of renal cell carcinoma

21 January 2018

1 reference

Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

21 January 2018

1 reference

Predictors of competing mortality in advanced head and neck cancer

21 January 2018

1 reference

Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.12.54

1 reference

27 August 2017

1 reference